{"schema_version":"1","generated_at":"2026-11-04T02:59:57.568Z","data_as_of":null,"url":"https://www.findmykol.com/kol/dan-douer","json_url":"https://www.findmykol.com/kol/dan-douer/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"dan-douer","name":"Dan Douer","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1700825171","orcid":"0000-0002-3693-8864","openalex":"A5111663910"},"summary":"Dan Douer is a Hematology physician. OpenAlex indexes 275 publications with 11,590 citations (h-index 48); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":275,"cited_by_count":11590,"h_index":48,"latest_activity_year":2025,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00672165","title":"Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT00672165","trial_url":"https://www.findmykol.com/trial/NCT00672165"},{"nct":"NCT00670150","title":"New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"University of Southern California","source_url":"https://clinicaltrials.gov/study/NCT00670150","trial_url":"https://www.findmykol.com/trial/NCT00670150"},{"nct":"NCT00184054","title":"Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"University of Southern California","source_url":"https://clinicaltrials.gov/study/NCT00184054","trial_url":"https://www.findmykol.com/trial/NCT00184054"}],"source":"trials"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":19,"shown":3,"withheld":16,"rows":[{"payer":"Servier BioInnovation","program_year":2025,"amount_usd":2210,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700825171"},{"payer":"SERVIER PHARMACEUTICALS LLC","program_year":2024,"amount_usd":11068.13,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700825171"},{"payer":"Amgen Inc.","program_year":2024,"amount_usd":981.01,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700825171"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1700825171","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion","year":2020,"journal":"ESMO Open","source_url":"https://doi.org/10.1136/esmoopen-2020-000858","status":"verified"},{"title":"How I Treat the Toxicities of Pegasparaginase in Adults with Acute Lymphoblastic Leukemia","year":2020,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2019002477","status":"verified"},{"title":"Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia","year":2018,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2017.5305","status":"verified"},{"title":"Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia","year":2018,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2017014175","status":"verified"},{"title":"Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience","year":2018,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.25162","status":"verified"}],"source":"works"},"contact":{"address_1":"1275 YORK AVE","city":"New York","state":"NY","zip":"100656007","phone":"212-639-2471","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700825171","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":16,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-08-04","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}